Comparative Study of HOE490 O (Glimepiride and Metformin) Compared With Placebo on Top of Glimepiride

Exclusion Criteria

• •Patients with HbA1c of \< 7.0 % and \> 11.0 %
• •Patients with any following laboratory test abnormality :
• •* ALT and/or AST: \> 3 X ULN
• •* Neutrophils: \< 1,000/mm3 and/or platelets \< 100,000/mm3
• •* Hemoglobin: \<11 g/dL
• •* Creatinine: \>= 1.3 mg/dL in case of male or \>= 1.0 mg/dL in case of female
• •The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.